Cytomegalovirus vaccines and methods of production
US10300130B2 · kind B2 · utility
0Cited by
7References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 29, 2016 |
| Grant date | May 28, 2019 |
| Priority date | — |
| Expiry date | Aug 31, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/16164
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of increasing diversity in cytomegalovirus vaccines through the selection of cell type in which the virus is propagated, and the use of cytomegalovirus produced by those methods in the development of vaccine compositions, are disclosed. Vaccine compositions comprising CMV isolated from epithelial cells are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.